Fresenius Medical, the leading global kidney dialysis company, takes US recovery as its bet. Fresenius Medical Care offers a variety of dialysis products including dialysis machines and dialyzers. These health care providers excel in both hemodialysis and peritoneal dialysis.
Overview of Fresenius Medical
Fresenius Health is a world-class healthcare business dedicated to the development of diagnostics, devices, and care programs targeting patients dealing with chronic kidney failure. Fresenius Medical Care is the world’s largest producer of dialysis machines and services. Their undertaking is to boost the conditions of the patients all over the world with this remedy.
History
The company has a long and unique historical background. Its main area of business is taking care of kidneys. They have been the driving force in developing a better system of dialysis and among other things, enhanced patient care over the years.
Vision and Mission
The vision of Fresenius Medical Care revolves around the provision of premium care to patients with kidney problems. Their purpose is to make the world a better place for people with kidney diseases by providing cutting-edge solutions and friendly consolation.
Core Values
Patient welfare is absolutely the number one priority. They concentrate on safety, quality, and continuous improvement of their products and services.
Global Reach
The company is global, managing 345 thousand dialysis patients in more than 60 countries. They devote their time and effort in going beyond boundaries so that patients undergoing renal care are in the right place.
Why the situation matters
The pandemic affected Fresenius Medical Care by leading to an increase in deaths of patients that weighed down the company’s shares. Conversely, the company anticipates higher patient volumes as the situation improves.
CEO’s Quotation
CEO Helen Giza expressed herself by saying, “This year, I’m pleased to say we anticipate U.S. treatment volumes to rebound from a subdued pandemic era by 0.5% to 2% by the end of 2024, keeping us on track to a return to pre-pandemic levels of 2% to 3% by the end of 2025.”
Quotation Source: finance.yahoo
Performance of first quarter
In the first quarter Fresenius Medical Care reported operating earnings above the expectations thanks to higher prices and cost cutting. The company’s earnings prospects for the year ending 2024 still remain intact.
Conclusion
Fresenius Medical Care is now able to focus on the enlargement of its operations in the U. S. dialysis market. Investors and patients alike will watch closely to see how well the company performs its mission of returning us back to the health levels before the pandemic. The company seeks to be responsible by developing productive value that is economical, ecological, and social.
Image Source: health.economictimes.indiatimes
Disclaimer – We have collected this information from various trustworthy sources on the Internet, and the facts have been checked manually and verified by our In House team.
